William Hurtado-Santiago, MD
Nephrology · Mayaguez, PRNPI 1912022310
Payments from drug & device makers
Across 412 payments — averaging $607.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$103K
- Boehringer Ingelheim$65K
- Calliditas Therapeutics US Inc.$40K
- Lilly USA, LLC$24K
- Bayer$6K
- Vertex$4K
- plus $8K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 148 | $102,991 |
| Boehringer Ingelheim | 50 | $64,924 |
| Calliditas Therapeutics US Inc. | 51 | $40,321 |
| Lilly USA, LLC | 28 | $23,675 |
| Bayer | 19 | $5,844 |
| Vertex | 1 | $4,411 |
| Johnson & Johnson | 10 | $2,677 |
| Amgen(2 entities) | 15 | $870 |
| Medtronic | 14 | $771 |
| Nxstage Medical, Inc. | 5 | $527 |
| Travere Therapeutics, Inc. | 7 | $489 |
| Boehringer Ingelheim International GmbH | 4 | $302 |
| ANI Pharmaceuticals, Inc. | 10 | $273 |
| Bard Access Systems, Inc. | 3 | $249 |
| Mallinckrodt Hospital Products Inc. | 4 | $188 |
| Novartis | 6 | $171 |
| Otsuka America Pharmaceutical, Inc. | 6 | $158 |
| Bayer Puerto Rico Inc. | 6 | $154 |
| Bard Peripheral Vascular, Inc. | 4 | $153 |
| E.r. Squibb & Sons, L.L.C. | 2 | $150 |
| BD | 6 | $127 |
| Apellis Pharmaceuticals, Inc. | 1 | $125 |
| Shionogi Inc | 1 | $123 |
| Perspectum Diagnostics Ltd | 1 | $117 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $104 |
| Boston Scientific | 3 | $103 |
| Kyowa Kirin, Inc. | 1 | $50 |
| GSK | 1 | $45 |
| Davol Inc. | 1 | $28 |
| Abbott | 1 | $22 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Merck | 1 | $12 |
How this compares
$250,170 in reported general payments places this provider in the 95th percentile of 161 nephrology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Mayaguez
- Jorge Weber AcevedoMayaguez$3K
- Eddie Rodriguez CastroToa Baja$591K
- Rafael Burgos CalderonBayamon$394K
- Eugenia Galindo RamosCaguas$360K
- Jose Cangiano-RiveraSan Juan$300K
- Ileana Ocasio MelendezDorado$261K
- Jacobo Loyola-TorresCaguas$145K
- Ricardo Calderon OrtizCaguas$97K
- Luis QuesadaSanturce$83K
- Jose Santiago SantiagoSan Juan$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.